[go: up one dir, main page]

Solberg et al., 1994 - Google Patents

A cleaved form of the receptor for urokinase‐type plasminogen activator in invasive transplanted human and murine tumors

Solberg et al., 1994

Document ID
5916846065470390453
Author
Solberg H
Rømer J
Brünner N
Holm A
Sidenius N
Danø K
Høyer‐Hansen G
Publication year
Publication venue
International journal of cancer

External Links

Snippet

It was recently found that urokinase‐type plasminogen activator (uPA) is involved in the cleavage of its receptor (uPAR) on cultured cells, thereby releasing one of the receptor's 3 domains (the ligand binding domain I) and leaving the 2 others [uPAR (2+ 3)] anchored to …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Similar Documents

Publication Publication Date Title
Solberg et al. A cleaved form of the receptor for urokinase‐type plasminogen activator in invasive transplanted human and murine tumors
Nielsen et al. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells-inhibitor neutralization and one-step affinity purification
Kobayashi et al. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
Krüger et al. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)
Skriver et al. Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma.
US6265551B1 (en) Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof
Roldan et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.
Sullivan et al. An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts
Müllertz et al. The primary inhibitor of plasmin in human plasma
Reilly et al. Type‐1 plasminogen activator inhibitor in human breast carcinomas
Kos et al. Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis
Höyhtyä et al. Modulation of type‐IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type‐IV collagenase
Duncan et al. Human matrix metalloproteinase‐9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form
HØYER-HANSEN et al. Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor
Nielsen et al. Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one‐step affinity purification.
Luther et al. Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue
WO1996038550A1 (en) A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
WO1996038550A9 (en) A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
Shimomura et al. Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form
Holvoet et al. Characterization of functional domains in human tissue‐type plasminogen activator with the use of monoclonal antibodies
Kurkinen et al. Polypeptides of human plasma fibronectin are similar but not identical
EP1281404A2 (en) Use of antibodies against the urokinase receptor
Gold et al. Localization of the ceavage sites on fibronectin following digestion by urokinase
Gissler et al. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis
Ohuchi et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies